Concept information
Preferred term
Fenretinide
Type
-
mesh:Descriptor
Definition
- A synthetic retinoid that is used orally as a chemopreventive against prostate cancer and in women at risk of developing contralateral breast cancer. It is also effective as an antineoplastic agent.
Broader concept
Entry terms
- 187EJ7QEXL
- 4-HPR
- 4-Hydroxyphenylretinamide
- 65646-68-6 (Fenretinide)
- 75686-07-6 (13-cis-isomer)
- Fenretinimide
- N-(4-Hydroxyphenyl)retinamide
- N-(4-Hydroxyphenyl)-trans-Retinamide
- Retinamide, N-(4-hydroxyphenyl)-
Allowable Qualifier(s)
- administration & dosage (Qualifier)
- adverse effects (Qualifier)
- agonists (Qualifier)
- analogs & derivatives (Qualifier)
- analysis (Qualifier)
- antagonists & inhibitors (Qualifier)
- blood (Qualifier)
- cerebrospinal fluid (Qualifier)
- chemical synthesis (Qualifier)
- chemistry (Qualifier)
- classification (Qualifier)
- economics (Qualifier)
- history (Qualifier)
- immunology (Qualifier)
- isolation & purification (Qualifier)
- metabolism (Qualifier)
- pharmacokinetics (Qualifier)
- pharmacology (Qualifier)
- poisoning (Qualifier)
- radiation effects (Qualifier)
- standards (Qualifier)
- supply & distribution (Qualifier)
- therapeutic use (Qualifier)
- toxicity (Qualifier)
- urine (Qualifier)
Pharmacological Action(s)
In other languages
-
French
-
187EJ7QEXL
-
4-HPR
-
65646-68-6 (Fenretinide)
-
75686-07-6 (13-cis-isomer)
-
Retinamide, N-(4-hydroxyphenyl)-
URI
http://data.loterre.fr/ark:/67375/JVR-N9DN9QH5-V
{{label}}
{{#each values }} {{! loop through ConceptPropertyValue objects }}
{{#if prefLabel }}
{{/if}}
{{/each}}
{{#if notation }}{{ notation }} {{/if}}{{ prefLabel }}
{{#ifDifferentLabelLang lang }} ({{ lang }}){{/ifDifferentLabelLang}}
{{#if vocabName }}
{{ vocabName }}
{{/if}}